Cargando…
Impact of retrospective data verification on the results of the academic-led ICON6 trial
Autores principales: | Embleton, Andrew, Clark, Elizabeth, Townsend, Stephen, Farrelly, Laura, Jones, Cheryl, Kaplan, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660294/ http://dx.doi.org/10.1186/1745-6215-16-S2-P184 |
Ejemplares similares
-
Impact of retrospective data verification to prepare the ICON6 trial
for use in a marketing authorization application
por: Embleton-Thirsk, Andrew, et al.
Publicado: (2019) -
Tissue factor-targeted immunotherapy of melanoma and triple negative breast cancer using a second generation ICON
por: Hu, Zhiwei, et al.
Publicado: (2015) -
Assessing fidelity to complex interventions: the icons experience
por: Chesworth, Brigit, et al.
Publicado: (2013) -
Challenges of the set-up process for academic led international studies of rare diseases
por: McColl, Elaine, et al.
Publicado: (2015) -
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial
por: Ledermann, J.A., et al.
Publicado: (2021)